It said: “Our witnesses pointed out that the problems with medicine supply to Northern Ireland are part of a wider set of issues affecting the sector, including the wider impact of Brexit on supply chains and product testing, issues with global supply chains, and shortages and rising costs of products since the COVID pandemic.
